Suppr超能文献

两种由于突变导致的甲状腺激素抵抗的新病例

Two Novel Cases of Resistance to Thyroid Hormone Due to Mutation.

机构信息

Centre de Biochimie Structurale, CNRS, INSERM, Univ Montpellier, Montpellier, France.

Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Sao Paulo, Brazil.

出版信息

Thyroid. 2020 Aug;30(8):1217-1221. doi: 10.1089/thy.2019.0602. Epub 2020 Apr 23.

Abstract

Resistance to thyroid hormone alpha (RTHα) is a rare and under-recognized genetic disease caused by mutations of , the gene encoding thyroid hormone receptor α1 (TRα1). We report here two novel missense mutations (M259T, T273A) in patients with RTHα. We combined biochemical and cellular assays with modeling to assess the capacity of mutant TRα1 to bind triiodothyronine (T3), to heterodimerize with RXR, to interact with transcriptional coregulators, and to transduce a T3 transcriptional response. M259T, and to a lower extent T273A, reduces the affinity of TRα1 for T3. Their negative influence is only reverted by large excess of T3. The severity of the two novel RTHα cases originates from a reduction in the binding affinity of TRα1 mutants to T3 and thus correlates with the incapacity of corepressors to dissociate from TRα1 mutants in the presence of T3.

摘要

甲状腺激素 α 抵抗(RTHα)是一种由甲状腺激素受体 α1(TRα1)基因编码突变引起的罕见且未被充分认识的遗传性疾病。我们在此报告了两名 RTHα 患者中存在的两种新的错义突变(M259T、T273A)。我们结合生化和细胞测定以及建模来评估突变型 TRα1 结合三碘甲状腺原氨酸(T3)、与 RXR 异二聚化、与转录共调节剂相互作用以及传递 T3 转录反应的能力。M259T,并且在较低程度上 T273A,降低了 TRα1 对 T3 的亲和力。只有大量 T3 才能逆转它们的负面影响。这两种新的 RTHα 病例的严重程度源于 TRα1 突变体与 T3 的结合亲和力降低,因此与在 T3 存在下共抑制剂从 TRα1 突变体解离的能力降低有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验